Schlabe, Stefan
Korir, Patricia
Lämmer, Christine
Landmann, Frederic
Dubben, Bettina
Koschel, Marianne
Albers, Anna
Debrah, Linda Batsa
Debrah, Alexander Yaw
Hübner, Marc P.
Pfarr, Kenneth https://orcid.org/0000-0003-3096-2465
Klarmann-Schulz, Ute
Hoerauf, Achim
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPPGH5342)
BONFOR
Deutsches Zentrum für Infektionsforschung, Clinical Leave Stipend (TI 07.001_Schlabe_00, TI 07.001_Schlabe_01)
Deutsches Zentrum für Infektionsforschung (TI 03.907, TI 03.907, TI 03.907)
Deutsche Forschungsgemeinschaft (EXC2151 – 390873048)
Universitätsklinikum Bonn
Article History
Received: 30 August 2021
Accepted: 14 December 2021
First Online: 10 January 2022
Declarations
:
: All participants of the prior studies (DOLF, ISRCTN50035143; MoRiOn, ISRCTN43697583; AWOL-Mino, ISRCTN68861628) gave their informed consent prior to study procedures according to local and national laws and in line with the requirements of Good Clinical Practice. All participants gave their informed consent for their samples to be biobanked and used for biomarker analysis. The informed consent included the consent to participate and consent to publication. The animal work was approved according to the rules of the animal welfare and protection act and national laws, specifically in accordance with the European Union Directive 2010/63/EU. Experiments were carried out after approval by the Landesamt fürNatur, Umwelt und Verbraucherschutz, Cologne, Germany (AZ 84–02.04.2015.A507).
: The authors declare no competing interests.